DailyMed will provide notification of updates and additions to Drug Label facts presently proven on This page by way of its RSS feed. A type of ketamine called esketamine nasal spray was authorised from the FDA in 2019 under the identify Spravato to be used in cure-resistant depression. The drug https://ketalinic.com/about-us/